DD273437A5 - Verfahren zur herstellung von dihydropyridin-derivaten - Google Patents

Verfahren zur herstellung von dihydropyridin-derivaten Download PDF

Info

Publication number
DD273437A5
DD273437A5 DD88314930A DD31493088A DD273437A5 DD 273437 A5 DD273437 A5 DD 273437A5 DD 88314930 A DD88314930 A DD 88314930A DD 31493088 A DD31493088 A DD 31493088A DD 273437 A5 DD273437 A5 DD 273437A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
alkyl
process according
methyl
Prior art date
Application number
DD88314930A
Other languages
German (de)
English (en)
Inventor
David Alker
Peter E Cross
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD273437A5 publication Critical patent/DD273437A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DD88314930A 1987-04-21 1988-04-20 Verfahren zur herstellung von dihydropyridin-derivaten DD273437A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878709447A GB8709447D0 (en) 1987-04-21 1987-04-21 Dihydropyridines

Publications (1)

Publication Number Publication Date
DD273437A5 true DD273437A5 (de) 1989-11-15

Family

ID=10616115

Family Applications (1)

Application Number Title Priority Date Filing Date
DD88314930A DD273437A5 (de) 1987-04-21 1988-04-20 Verfahren zur herstellung von dihydropyridin-derivaten

Country Status (19)

Country Link
US (1) US4957930A (cs)
EP (1) EP0295769A3 (cs)
JP (1) JPS63280062A (cs)
KR (1) KR880012554A (cs)
CN (1) CN88102381A (cs)
AU (1) AU592498B2 (cs)
CS (1) CS270242B2 (cs)
DD (1) DD273437A5 (cs)
DK (1) DK213988A (cs)
FI (1) FI881824L (cs)
GB (1) GB8709447D0 (cs)
HU (1) HUT46894A (cs)
IL (1) IL86108A0 (cs)
NO (1) NO881709L (cs)
NZ (1) NZ224298A (cs)
PL (1) PL271920A1 (cs)
PT (1) PT87272A (cs)
YU (1) YU78388A (cs)
ZA (1) ZA882765B (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2014089C (en) * 1989-07-21 1997-01-14 Vernon L. Lamb Apparatus and method for making pressboard from poly-coated paper using relative movement of facing webs
CN103274993A (zh) * 2013-06-13 2013-09-04 南京工业大学 二氢吡啶和吡咯类杂环的新合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
IL78642A0 (en) * 1985-05-03 1986-08-31 Pfizer Dihydropyridines and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK213988A (da) 1988-10-22
CS270242B2 (en) 1990-06-13
AU1478788A (en) 1988-10-27
CS273488A2 (en) 1989-10-13
PL271920A1 (en) 1989-03-20
NO881709D0 (no) 1988-04-20
IL86108A0 (en) 1988-11-15
GB8709447D0 (en) 1987-05-28
YU78388A (en) 1990-04-30
DK213988D0 (da) 1988-04-20
HUT46894A (en) 1988-12-28
NO881709L (no) 1988-10-24
KR880012554A (ko) 1988-11-28
EP0295769A3 (en) 1989-02-08
AU592498B2 (en) 1990-01-11
FI881824A7 (fi) 1988-10-22
FI881824A0 (fi) 1988-04-19
US4957930A (en) 1990-09-18
ZA882765B (en) 1989-12-27
EP0295769A2 (en) 1988-12-21
PT87272A (pt) 1989-05-12
CN88102381A (zh) 1988-11-09
JPS63280062A (ja) 1988-11-17
FI881824L (fi) 1988-10-22
NZ224298A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
DE3787346T2 (de) Dihydropyridin-Derivate, ihre Herstellung und ihre Verwendung.
DD202430A5 (de) Verfahren zur herstellung von dihydropyridinen
EP0176956B1 (de) Neue Diarylverbindungen
DD154014A5 (de) Verfahren zur herstellung von optisch aktiven-1,4-dihydropyridinen
DD218887A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
CH618425A5 (cs)
DE29724281U1 (de) 4-Phenylpiperidin-Verbindungen
DD282008A5 (de) Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten
WO1988007525A1 (fr) Enantiomeres de 1,4-dihydropyridine
DE2549841A1 (de) Piperidylidenderivate, deren salze, verfahren zu ihrer herstellung und arzneipraeparate
DD229407A5 (de) Verfahren zur herstellung von piperidindion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet aufweisen
DE3042769A1 (de) C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
EP0039863B1 (de) 1,4-Dihydropyridine mit unterschiedlichen Substituenten in 2- und 6-Position, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0179386B1 (de) 1,4-Dihydropyridin-hydroxyamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE3311003A1 (de) Chromon- und thiochromonsubstituierte 1,4-dihydropyridinlactone, mehrere verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3782378T2 (de) Dihydropyridinderivate und deren pharmazeutische zusammensetzungen.
DE3607821A1 (de) Aminoester-dihydropyridine, verfahren zur herstellung und ihre verwendung
DE68912252T2 (de) Imidazolantiarrythmische Mittel.
CH633265A5 (de) Verfahren zur herstellung des neuen 1.4-dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsaeure-isopropyl-(2-propoxy-aethyl)-esters.
EP0362632A2 (de) Basische 4-Aryl-DHP-amide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE2549568A1 (de) 2,6-dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsaeureisobutylester, mehrere verfahren zu seiner herstellung sowie seine verwendung als coronartherapeutikum
EP0362635A1 (de) Verfahren von basischen Nitrophenyl-dihydropyridinamiden als Arzneimittel, neue Verbindungen und Verfahren zu ihrer Herstellung über neue Zwischenprodukte
DE3414801A1 (de) 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2359359A1 (de) Fluor-substituierte thioxanthene und verfahren zu deren herstellung sowie diese enthaltende pharmazeutische mittel
EP0657432B1 (de) Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee